BIT's 16th Annual Congress of International Drug Discovery Science & Technology-China 2018
★ Welcome Message

Dear Friends and Colleagues,

It is my honor and pleasure to welcome you to the 16th Annual Congress of International Drug Discovery Science & Technology-China 2018  with theme of “Theme: Focusing on Biomedical Frontiers, Driving Industrial Innovative Development”, which will be held during November 6-8, 2018 in the beautiful city of Jinan, China.

With 15 years’ of persistent efforts, the IDDST congress has successfully attracted more than 10,000 world renowned speakers with over 50,000 professionals around the world as a leading international event for our drug discovery community.

IDDST- China 2018 will host leading scientists from the academia and industry worldwide, to discuss the latest developments in drug discovery and therapy. 300 participants from 30 countries will gather in beautiful Jinan for the event. 60% of attendees will come from the pharmaceutical industry with an additional 40% from academia. With clinical drug development in Asia growing so rapidly, the IDDST- China 2018 promises to be one of the most exciting opportunities for those who are seeking to broaden their professional network!

The Chinese Pharmaceutical market is currently the second greatest pharma market globally, after the US. China has around 6,000 domestic pharmaceutical manufacturers, and also attracts many internationally renowned pharmaceutical companies. Joining in IDDST-China 2018, you will meet executives and scientists from those world top pharmaceutical companies and Universities.

On behalf of the Organizing Committee of IDDST-China 2018, I would firstly welcome all new participants and old friends again for your passionate involvements to these annual events. Secondly, I appreciate so much to all our scientific advisors, session organizers, supporters and hardworking organizing committee members for their enormous efforts to bring this grand program together. 

Sincerely Yours,



Xiaodan Mei, Ph.D.
Executive Chair of IDDST-China 2018
President, BIT Group Global Ltd.
News Release
Full Program Released 说明: http://www.bitcongress.com/nano2018/images/NEW015.gif
● Call for Supporting Organizations and Media Partners
● Call for Session Chairs and Speakers 
● Call for Exhibitors and Sponsors
Hosting Organizations

Information Research Center of International Talent, SAFEA


Jinan Innovation Zone
Supporting Organizations


Ji'nan Branch of China Council for The Promotion of International Trade


University of South Australia



School of Biological Engineering, Qilu University of Technology

Operating Organizations
Official Travel Agency
Exhibition
Participating Organizations

Amgen, Inc.
Arrowhead Pharmaceuticals Inc.
Eisai Co., Ltd.
ChemDiv, Inc.
University of Queensland
Comenius University
Fountain Medical Development Ltd.,
McGill University
Pharmaron Inc.
Pfizer Inc.
Florida State University
Shanghai Jiaotong University School of Medicine
Leydig, Voit & Mayer, Ltd.
University of Pittsburgh
F. Hoffmann-La Roche
Tactical Therapeutics, Inc.
Leadscope Inc.
AbbVie Deutschland GmbH & Co. KG
Merck KGaA
Genentech, Inc.
Sanofi
Hamamatsu Photonics K.K.
University of Arizona
ChemDiv, Inc
AbMax Biotechnology Inc.
University Hospital Brno and Medical Faculty of Masaryk University
PSMMC, Riyadh
Boehringer Ingelheim Pharma GmbH & Co. KG
Global PKPD & Pharmacometrics, Eli Lilly and Company
Beijing Institute of Pharmacology and Toxicology
Auckland UniVersity
Cyclenium Pharma Inc.
Helmholtz Centre for Infection Research
University of Arizona
Medlab Clinical Pty Ltd.
National Institute of Biological Sciences, Beijing
Quinnipiac University/King Lee PhD, LCC
Novartis Institue of Biomedical Research
IriSys, LLC,
Private Clinic of Dermatovenerology Svidník
Saarland University
Cardiff University

Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609-826, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.